Differences in pediatric SARS-CoV-2 symptomology and Co-infection rates among COVID-19 Pandemic waves

Brian R Lee; Christopher J Harrison; Angela L Myers; Mary Anne Jackson; Rangaraj Selvarangan

doi:10.1016/j.jcv.2022.105220

Differences in pediatric SARS-CoV-2 symptomology and Co-infection rates among COVID-19 Pandemic waves

J Clin Virol. 2022 Sep:154:105220. doi: 10.1016/j.jcv.2022.105220. Epub 2022 Jun 23.

Authors

Brian R Lee¹, Christopher J Harrison², Angela L Myers², Mary Anne Jackson², Rangaraj Selvarangan³

Affiliations

¹ Division of Health Services and Outcomes Research, Children's Mercy Hospitals, 2401 Gillham Road, Kansas City, Missouri 64108 United States; School of Medicine, University of Missouri Kansas City, 2411 Holmes Street, Kansas City, Missouri 64108 United States. Electronic address: blee@cmh.edu.
² School of Medicine, University of Missouri Kansas City, 2411 Holmes Street, Kansas City, Missouri 64108 United States; Division of Infectious Diseases, Children's Mercy Hospitals, 2401 Gillham Road, Kansas City, Missouri 64108 United States.
³ School of Medicine, University of Missouri Kansas City, 2411 Holmes Street, Kansas City, Missouri 64108 United States; Department of Pathology and Laboratory Medicine, 2401 Gillham Road, Kansas City, Missouri 64108 United States. Electronic address: rselvarangan@cmh.edu.

Abstract

An estimated 12.8 million pediatric SARS-CoV-2 infections have occurred within the United States as of March 1 2022, with multiple epidemic waves due to emergence of several SARS-CoV-2 variants. The aim of this study was to compare demographics, clinical presentation, and detected respiratory co-infections during COVID-19 waves to better understand changes in pediatric SARS-CoV-2 epidemiology over time.

MeSH terms

COVID-19*
Child
Coinfection* / epidemiology
Humans
Pandemics
SARS-CoV-2
United States / epidemiology

Supplementary concepts

SARS-CoV-2 variants